Cannabis Financial Statements From 2010 to 2024

CSUI Stock  USD 0.02  0  5.56%   
Cannabis Suisse financial statements provide useful quarterly and yearly information to potential Cannabis Suisse Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cannabis Suisse financial statements helps investors assess Cannabis Suisse's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cannabis Suisse's valuation are summarized below:
Cannabis Suisse Corp does not presently have any fundamental signals for analysis.
Check Cannabis Suisse financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cannabis Suisse's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cannabis financial statements analysis is a perfect complement when working with Cannabis Suisse Valuation or Volatility modules.
  
This module can also supplement various Cannabis Suisse Technical models . Check out the analysis of Cannabis Suisse Correlation against competitors.

Cannabis Suisse Corp Company Shares Outstanding Analysis

Cannabis Suisse's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Cannabis Suisse Shares Outstanding

    
  40.65 M  
Most of Cannabis Suisse's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabis Suisse Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Cannabis Suisse Corp has 40.65 M of shares currently outstending. This is 77.48% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 92.89% higher than that of the company.

Cannabis Suisse Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cannabis Suisse's current stock value. Our valuation model uses many indicators to compare Cannabis Suisse value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannabis Suisse competition to find correlations between indicators driving Cannabis Suisse's intrinsic value. More Info.
Cannabis Suisse Corp is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cannabis Suisse by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cannabis Suisse's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Cannabis Suisse Financial Statements

Investors use fundamental indicators, such as Cannabis Suisse's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cannabis Suisse's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California. CANNABIS SUISSE is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Cannabis Pink Sheet

Cannabis Suisse financial ratios help investors to determine whether Cannabis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannabis with respect to the benefits of owning Cannabis Suisse security.